Developing and Testing Drone-Delivered AEDs for Cardiac Arrests In Rural America
Launched by DUKE UNIVERSITY · Jan 19, 2024
Trial Information
Current as of May 18, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to deliver Automated External Defibrillators (AEDs) using drones in rural areas. AEDs are devices that can help restart the heart during a cardiac arrest, which is when the heart suddenly stops beating. The goal of this project is to see if drones can get these lifesaving devices to people experiencing cardiac arrest faster than current emergency services can. By testing this method, the researchers hope to find out if it can improve the chances of survival for patients who experience cardiac arrest outside of a hospital.
To participate in this trial, individuals must be at least 18 years old and have experienced a non-traumatic cardiac arrest before help arrives. This means that if someone had a heart attack or their heart stopped beating and a bystander used an AED on them before emergency responders arrived, they may be eligible. It's important to note that this trial is still in the planning stages and is not currently recruiting participants. If you or a loved one meets the criteria, you may have an opportunity to contribute to important research that could improve emergency care in rural communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 18 years of age or older in the CARES registry who suffer cardiac arrest before arrival of a 911-responder of non-traumatic cause, including patients who receive an AED shock by a bystander prior to the arrival of 911 responders.
- Exclusion Criteria:
- • Patients in the CARES registry who have a traumatic cause of cardiac arrest.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Monique Starks, MD
Principal Investigator
Duke University
Daniel Mark, MD
Principal Investigator
Duke University
Joseph Ornato, MD
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported